Imetelstat
spdr s&p biotech,ishares biotechnology,Geron Corporation
['mds', '$ibb', '$xbi']
$gern geron's imetelstat presents promising results in imerge phase 3 trial showing durable transfusion independence in lower risk mds patients at asco presentation more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt